Peter Dornbos Selected Research

Peter Dornbos Research Topics

3	Non-alcoholic Fatty Liver Disease 01/2021 - 12/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2018 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2016 - 01/2016
1	Type 2 Diabetes Mellitus (MODY) 11/2022
1	Abdominal Obesity 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Chloracne 11/2018
1	Fibrosis (Cirrhosis) 12/2016
1	Inflammation (Inflammations) 12/2016
1	Wasting Syndrome (Wasting Disease) 01/2016
1	Hypoxia (Hypoxemia) 01/2015

5	Polychlorinated Dibenzodioxins (TCDD)IBA 11/2019 - 01/2016
2	LigandsIBA 01/2021 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2015
1	Hemoglobins (Hemoglobin)IBA 11/2022
1	Activins (Activin)IBA 01/2022
1	CorticosteroneIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	1,4-dioxinIBA 11/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2016
1	CarbonIBA 12/2016
1	CollagenIBA 12/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2016
1	Glucose (Dextrose)FDA LinkGeneric 12/2016
1	GlycogenIBA 12/2016
1	Liver GlycogenIBA 12/2016
1	NADP (NADPH)IBA 12/2016
1	Proline (L-Proline)FDA Link 12/2016
1	Serine (L-Serine)FDA Link 12/2016
1	Amino Acids FDA Link 12/2016
1	Oxygen (Dioxygen)IBA 01/2015